Jump to:

Immunodiagnostic Systems Holdings Fundamentals

Company Name Immunodiagnostic System Last Updated 23 May 2019
Industry Health Care Sector Medical Equipment
Shares in Issue (m) 28.78 Market Cap (£m) 57.57
PE Ratio 47.62 Div per Share (p) 1.70
Div Yield 0.85 Div Cover 2.47
EPS 4.20 EPS Growth (%) -58.82
PEG -0.81 DPS Growth (%) -57.50
Debt Ratio 5.65 Debt Equity Ratio 0.32
Net Gearing -26.45 Gross Gearing 15.80
Asset Equity Ratio 1.19 Cash Equity Ratio 50.17
Quick Ratio 5.50 Current Ratio 6.66
Price To Book Value 1.01 ROCE 1.56

Immunodiagnostic Systems Holdings Dividends

Type Ex-Date Pay Date Currency Net Dividend Year Total
H2 Dividend 19 Jul 2018 17 Aug 2018 GBX 1.70 1.70
H2 Dividend 20 Jul 2017 18 Aug 2017 GBX 4.00 4.00
H2 Dividend 21 Jul 2016 19 Aug 2016 GBX 1.20 1.20
H2 Dividend 23 Jul 2015 21 Aug 2015 GBX 3.00 3.00
H2 Dividend 23 Jul 2014 22 Aug 2014 GBX 8.50 8.50

Immunodiagnostic Systems Holdings Company Financials

Assets (£m) 2018 2017 2016
Tangible Assets 7 9 10
Intangible Assets 11 10 9
Investments 1 1 0
Total Fixed Assets 19 20 19
Stocks 8 8 8
Debtors 8 8 7
Cash & Equivalents 29 32 27
Other Assets 3 2 2
Total Assets 68 69 62
Liabilities (£m) 2018 2017 2016
Creditors within 1 year 7 8 7
Creditors after 1 year 3 4 4
Other Liabilities 0 0 0
Total Liabilities 11 12 11
Net assets 57 57 52
Equity (£m) 2018 2017 2016
Called up share capital 1 1 1
Share Premium 32 32 32
Profit / Loss 1 1 -37
Other Equity 5 5 2
Preference & Minorities 0 0 0
Total Capital Employed 57 57 52
Ratios 2018 2017 2016
Debt Ratio 5.65 6.25 7.51
Debt-to-Equity 0.32 0.32 0.39
Net Gearing -26.45 -28.36 -25.36
Gross Gearing 15.80 17.46 17.23
Assets / Equity 1.19 1.21 1.21
Cash / Equity 50.17 55.52 51.46
EPS 4.20 10.20 -109.70
Cash Flow (£m) 2018 2017 2016
Cash from operating activities 3 8 8
Cashflow before financing -1 5 3
Increase in Cash -1 4 2
Income (£m) 2018 2017 2016
Turnover 38 40 38
Cost of sales 20 17 16
Gross Profit 18 23 22
Operating Profit 1 2 -37
Pre-Tax profit 1 1 -37
Profit / Loss for the year 1 1 1

Immunodiagnostic Systems Holdings Company Background

Sector Medical Equipment
Activities Immunodiagnostic Systems Holdings plc (IDS) is a specialist in-vitro diagnostic solution provider to the clinical laboratory market and producer of manual and automated diagnostic testing kits and instruments for the clinical market.
Latest Interim Date 23 Nov 2018
Latest Fiscal Year End Date 20 Jun 2018

Immunodiagnostic Systems Holdings Directors

Appointed Director Position
31 Oct 2017 Jaap Stuut Chief Executive Officer
04 Jan 2016 Paul James Martin Chief Financial Officer
25 Nov 2014 Dr Burkhard Wittek Non-Executive Chairman
01 Nov 2015 Klaus Peter Kaspar Non-Executive Director
15 Jun 2015 Peter John Williamson Non-Executive Director

Immunodiagnostic Systems Holdings Contact Details

Company Name Immunodiagnostic System
Company Address 10 Didcot Way, Boldon Business Park, Boldon, Tyne & Wear NE35 9PD.
Company Telephone +44 (0)191 519 0660
Company Website http://www.idsplc.com/

Immunodiagnostic Systems Holdings Advisors

Auditor Name Baker Tilly
Auditor Address 1 St James Gate, Newcastle upon Tyne NE1 4AD.
Auditor Website http://www.bakertilly.co.uk/
Auditor Telephone +44 (0)1483 307 000
Registrar Name Computershare Investor Service
Registrar Address The Pavillions, Bridgwater Road, Bristol BS99 1XZ.
Registrar Website http://www-uk.computershare.com/
Registrar Telephone 0870 702 0010
Broker Name N+1 Singer
Broker Address One Bartholomew Lane, London EC2N 2AX.
Broker Website http://www.n1singer.com/
Broker Telephone +44 (0)20 7496 3000
Adviser Name N+1 Singer
Adviser Address One Bartholomew Lane, London EC2N 2AX.
Adviser Website http://www.n1singer.com/
Adviser Telephone +44 (0)20 7496 3000
Solicitor Name Watson Burton
Solicitor Address 1 St James' Gate, Newcastle upon Tyne NE99 1YQ.
Solicitor Website http://www.watsonburton.com/
Solicitor Telephone +44 (0)1912 444 444
Stockbroker Name n/a
Stockbroker Address n/a
Stockbroker Website n/a
Stockbroker Telephone n/a